23.15USD+8.56%Mkt Cap: 3.34B USDP/E: —Last update: 2026-06-01
Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative prot…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap3.34B USD
Enterprise Value2.83B USD
Revenue (TTM)56.99M USD
Gross Profit-72.27M USD
Net Income (TTM)-101.59M USD
Revenue/Share0.4580 USD
Last Price23.15 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees137
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-13.82
PEG—
EV/EBITDA-24.54
EV/Revenue49.70
P/S55.79
P/B8.63
EPS (TTM)-0.83
EPS (Forward)-1.59
52W Range
2.12180% of range28.41
52W High28.41 USD
52W Low2.121 USD
Profitability
Gross Margin-126.80%
Oper. Margin-206.22%
EBITDA Margin-202.50%
Profit Margin-162.85%
ROE-29.35%
ROA-25.48%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-138.89M USD
CapEx (TTM)1.05M USD
FCF Margin-119.73%
FCF Yield-2.04%
Net Debt-347.05M USD
Net Debt/EBITDA3.01
Balance Sheet
Debt/Equity0.10
Current Ratio27.38
Quick Ratio26.51
Book Value/Sh2.547 USD
Cash/Share2.626 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)31.90 USD
Target Range21.00 USD – 55.00 USD
# Analysts10
Ownership
Shares Out.144.65M
Float69.60M
Insiders1.38%
Institutions127.00%
Short Interest
Short Ratio9.8d
Short % Float22.28%
Short % Out.21.99%
Shares Short31.81M
Short (prev mo.)40.25M
Technical
SMA 5022.26 (+4.0%)
SMA 20012.89 (+79.5%)
Beta1.22
S&P 52W Chg27.70%
Avg Vol (30d)2.86M
Avg Vol (10d)3.05M
Technical Indicators
RSI (14)47.8
MACD-0.6377
MACD Signal-0.3391
MACD Hist.-0.2986
BB Upper25.64 USD
BB Middle22.05 USD
BB Lower18.45 USD
BB Width32.61%
ATR (14)1.672 USD
Vol Ratio (20d)0.38x